Medical Cannabis Payment Solutions (REFG)

[I-Man]

Hey searching, right now ARYC has already gone down that road and like 4 years behind on reporting, and SEC does nothing. An over 20 year bio-medical company, with major positioning in that market too. Because under SEC rules, for an OTC, there is no definitive date of which to report, and that company's CEO keeps building hope, yet stretches out docs and filings, and essentially, as long as they are on OTC, they can get away with it.

Why they need to uplist to legitimate exchange and go from there.

No trust on OTC no matter how good your company and products are as is case right now with ARYC...